Sign in
8-K

Current Report

Prelude Therapeutics Inc Filed Acc 0001193125-22-005032

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading d208811d8k.htm…